Dr. Sha is a Clinical Associate Professor of Neurology and Neurological Sciences at Stanford University where she serves as the Medical Director of the Stanford Neuroscience Clinical Trials Group, Co-Director of the Huntington’s Disease Center of Excellence and Ataxia Clinic, Co-Director of the Lewy Body Disease Association Research Center of Excellence, Clinical Core Co-Leader of the Stanford Alzheimer's Disease Research Center, and Director of the Behavioral Neurology Fellowship. Her clinical time is devoted to caring for patients with Alzheimer’s disease and other neurodegenerative disorders. Her research is devoted to finding treatments for cognitive disorders. Her recent work focused on the safety of young plasma for the treatment of Alzheimer’s disease.
Dr. Sha received a Master’s degree in Physiology and an MD from Georgetown University, followed by Neurology training at UCLA and Stanford University. She completed a clinical and research fellowship in Behavioral Neurology at UCSF, where she focused on identifying biomarkers for genetic forms of frontotemporal dementia and caring for patients with movement disorders with cognitive impairment.
- Huntington Disease
- Alzheimer Disease
- Frontotemporal Dementia
Clinical Associate Professor, Neurology & Neurological Sciences
Associate Chair, Medical Director, Stanford Neurosciences Clinical Trials Group (2016 - Present)
Director, Behavioral Neurology and Neuropsychiatry Fellowship (2015 - Present)
Medical Education:Georgetown University Internal Medicine Residency (2006) DC
Internship:California Pacific Medical Center Dept of Ophthalmology (2007) CA
Fellowship:University of California at San Francisco School of Medicine (2013) CA
Board Certification: Behavioral Neurology and Neuropsychiatry, United Council for Neurologic Subspecialties (2014)
Residency:Stanford University School of Medicine (2010) CA
Board Certification: Neurology, American Board of Psychiatry and Neurology (2010)
Residency:University of California Los Angeles (2008) CA